ResearcherFifth Affiliated Hospital of Sun Yat-sen UniversityActive in the last 2 years
Yin-Hao Shi
Matched on OpenAlex author ID A5009343674. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 3, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 16
2023: 1 paper · 2024: 5 papers · 2025: 1 paper
Papers 7
- Outcomes of extended versus standard lymphadenectomy in pancreatoduodenectomy for pancreatic cancer: systematic review and meta-analysis. First author DOI 10.3389/fonc.2025.1622966↗
- Epigenetic Activation of the CMTM6-IGF2BP1-EP300 Positive Feedback Loop Drives Gemcitabine Resistance in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1002/advs.202406714↗
- Platelet-Derived Growth Factor C Facilitates Malignant Behavior of Pancreatic Ductal Adenocarcinoma by Regulating SREBP1 Mediated Lipid Metabolism. Co-author DOI 10.1002/advs.202407069↗
- CSNK2A1 confers gemcitabine resistance to pancreatic ductal adenocarcinoma via inducing autophagy. First author DOI 10.1016/j.canlet.2024.216640↗
- Turning to immunosuppressive tumors: Deciphering the immunosenescence-related microenvironment and prognostic characteristics in pancreatic cancer, in which GL… Co-author DOI 10.1016/j.heliyon.2024.e36684↗
- N6-methyladenosine modified TGFB2 triggers lipid metabolism reprogramming to confer pancreatic ductal adenocarcinoma gemcitabine resistance. First author DOI 10.1038/s41388-024-03092-3↗
- Imatinib facilitates gemcitabine sensitivity by targeting epigenetically activated PDGFC signaling in pancreatic cancer. Co-author DOI 10.1016/j.ymthe.2022.11.004↗
Closest collaborators
The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Ying‐Qin Zhu · 6 shared papers, 2023–2024 · strength 1.13
- Paper Turning to immunosuppressive tumors: Deciphering the immunosenescence-related microenvironment and prognostic character… DOI 10.1016/j.heliyon.2024.e36684↗
- Paper N6-methyladenosine modified TGFB2 triggers lipid metabolism reprogramming to confer pancreatic ductal adenocarcinoma ge… DOI 10.1038/s41388-024-03092-3↗
- Paper Platelet-Derived Growth Factor C Facilitates Malignant Behavior of Pancreatic Ductal Adenocarcinoma by Regulating SREBP… DOI 10.1002/advs.202407069↗
- Zhide Liu · 6 shared papers, 2023–2024 · strength 1.13
- Paper Turning to immunosuppressive tumors: Deciphering the immunosenescence-related microenvironment and prognostic character… DOI 10.1016/j.heliyon.2024.e36684↗
- Paper N6-methyladenosine modified TGFB2 triggers lipid metabolism reprogramming to confer pancreatic ductal adenocarcinoma ge… DOI 10.1038/s41388-024-03092-3↗
- Paper Platelet-Derived Growth Factor C Facilitates Malignant Behavior of Pancreatic Ductal Adenocarcinoma by Regulating SREBP… DOI 10.1002/advs.202407069↗
- Mingjian Ma · 5 shared papers, 2024 · strength 0.97
- Paper Turning to immunosuppressive tumors: Deciphering the immunosenescence-related microenvironment and prognostic character… DOI 10.1016/j.heliyon.2024.e36684↗
- Paper N6-methyladenosine modified TGFB2 triggers lipid metabolism reprogramming to confer pancreatic ductal adenocarcinoma ge… DOI 10.1038/s41388-024-03092-3↗
- Paper Platelet-Derived Growth Factor C Facilitates Malignant Behavior of Pancreatic Ductal Adenocarcinoma by Regulating SREBP… DOI 10.1002/advs.202407069↗
- Jie‐Qin Wang · 5 shared papers, 2023–2024 · strength 0.92
- Paper N6-methyladenosine modified TGFB2 triggers lipid metabolism reprogramming to confer pancreatic ductal adenocarcinoma ge… DOI 10.1038/s41388-024-03092-3↗
- Paper Platelet-Derived Growth Factor C Facilitates Malignant Behavior of Pancreatic Ductal Adenocarcinoma by Regulating SREBP… DOI 10.1002/advs.202407069↗
- Paper Epigenetic Activation of the CMTM6-IGF2BP1-EP300 Positive Feedback Loop Drives Gemcitabine Resistance in Pancreatic Duc… DOI 10.1002/advs.202406714↗
- Xiao-Yu Yin · 4 shared papers, 2024 · strength 0.75
- Paper N6-methyladenosine modified TGFB2 triggers lipid metabolism reprogramming to confer pancreatic ductal adenocarcinoma ge… DOI 10.1038/s41388-024-03092-3↗
- Paper Platelet-Derived Growth Factor C Facilitates Malignant Behavior of Pancreatic Ductal Adenocarcinoma by Regulating SREBP… DOI 10.1002/advs.202407069↗
- Paper Epigenetic Activation of the CMTM6-IGF2BP1-EP300 Positive Feedback Loop Drives Gemcitabine Resistance in Pancreatic Duc… DOI 10.1002/advs.202406714↗
- Xi‐Tai Huang · 4 shared papers, 2024 · strength 0.75
- Paper N6-methyladenosine modified TGFB2 triggers lipid metabolism reprogramming to confer pancreatic ductal adenocarcinoma ge… DOI 10.1038/s41388-024-03092-3↗
- Paper Platelet-Derived Growth Factor C Facilitates Malignant Behavior of Pancreatic Ductal Adenocarcinoma by Regulating SREBP… DOI 10.1002/advs.202407069↗
- Paper Epigenetic Activation of the CMTM6-IGF2BP1-EP300 Positive Feedback Loop Drives Gemcitabine Resistance in Pancreatic Duc… DOI 10.1002/advs.202406714↗
- Xiao-Feng Li · 1 shared paper, 2025 · strength 0.42
- Yu-Chun Xu · 1 shared paper, 2025 · strength 0.42
- Chen‐Song Huang · 2 shared papers, 2023–2024 · strength 0.35
- Paper Epigenetic Activation of the CMTM6-IGF2BP1-EP300 Positive Feedback Loop Drives Gemcitabine Resistance in Pancreatic Duc… DOI 10.1002/advs.202406714↗
- Paper Imatinib facilitates gemcitabine sensitivity by targeting epigenetically activated PDGFC signaling in pancreatic cancer. DOI 10.1016/j.ymthe.2022.11.004↗
- Xiao Yu Yin · 1 shared paper, 2024 · strength 0.22
- De-Liang Fang · 1 shared paper, 2024 · strength 0.22
- Siyuan Lu · 1 shared paper, 2024 · strength 0.22
- Wei Zhao · 1 shared paper, 2024 · strength 0.18
- Yue Huang · 1 shared paper, 2024 · strength 0.18
- Qi Liu · 1 shared paper, 2023 · strength 0.16
- Xiaoyu Yin · 1 shared paper, 2023 · strength 0.16
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.